Patent Infringement

Related by string. patent infringement * patents : patent infringement suit / infringements : constitutes copyright infringement liable * patent infringement lawsuit . patent infringement lawsuits . Patent Infringement Lawsuit Against . frivolous patent infringement . Files Patent Infringement Lawsuit . Patent Infringement Suit Against . Rambus patent infringement *

Related by context. All words. (Click for frequent words.) 85 Files Patent Infringement 81 Patent Infringement Lawsuit 81 Wins Patent Infringement 81 Patent Lawsuit 80 Patent Infringement Case 80 Files Patent 79 Patent Suit 79 Patent Dispute 78 Settles Patent 77 Patent Infringement Suit 77 Patent Infringement Action 77 Patent Ruling 76 Patent Infringement Lawsuit Against 75 Patent Suit Against 75 Settle Patent Litigation 75 Settle Patent 75 Settles Patent Litigation 74 Patent Infringement Litigation 74 Infringed 74 Files Patent Infringement Suit 74 Patent Suits 74 Files Patent Infringement Lawsuit 74 Patent Infringement Claim 74 Infringement Case 73 Patent Lawsuit Against 73 Receives Favorable Ruling 73 Countersuit 73 Patent Infringement Claims 73 Patent Infringement Lawsuits 72 Infringes 72 Wins Summary Judgment 72 False Advertising 72 Patent Infringement Suit Against 72 Announces Dismissal 72 Settle Litigation 72 Settles Litigation 71 Announce Settlement 71 Preliminary Injunction Against 71 Trademark Infringement 71 Infringement Suit 71 Settles Patent Infringement Lawsuit 71 Initiates Patent Infringement 70 Announces Favorable Ruling 70 Files Lawsuits 70 Patent Disputes 70 Antitrust Suit 70 Antitrust Lawsuit 69 Settle Patent Dispute 69 Receives Patent 69 Antitrust Case 69 Favorable Ruling 69 Pomerantz Law Firm 69 Settles Charges 69 Injunction Against 68 Trademark Dispute 68 Antitrust Probe 68 Patent Reexamination 68 Patent Litigation 68 Acacia Subsidiary 68 Settles Patent Dispute 68 Copyright Infringement 68 Awarded Patent 67 Shareholder Lawsuit 67 Patent Infringements 67 Action Suit 67 Patents Upheld 67 Files Suit 67 Infringe 67 Declaratory Judgment 67 Complaint Against 67 Announce License Agreement 67 Legal Dispute 66 Patent Validity 66 Files Antitrust Suit 66 Announces Favorable 66 Action Suit Against 66 Gets Favorable 66 Receives Notification 66 Antitrust Violations 66 Receives Favorable 66 Reaches Settlement Agreement 66 Judge Tosses Out 66 Files Patent Suit 66 Wins Dismissal 66 Jury Verdict 66 Shareholder Derivative 66 Develop Next Generation 66 Pending Litigation 66 Complaint Filed 66 Trademark Lawsuit 66 Vigorously Defend 66 Files Countersuit Against 66 Sign License Agreement 66 Backdating Case 66 Announces Immediate Availability 66 Patent Spat 65 Purported Class 65 Licensing Pact 65 Files Motion 65 Begins Shipment 65 Announces FDA Clearance 65 Completes Tender Offer 65 HSR Waiting Period 65 Starts Shipping 65 Shareholder Suits 65 Nasdaq Delisting 65 Unveils Next Generation 65 Files Suit Against 65 Signs License Agreement 65 Patent Upheld 65 Price Fixing 65 Files Trademark 65 Discontinues 65 Patent Issued 65 Q1 Loss Widens 65 Antitrust Settlement 65 Derivative Lawsuit 65 Acquire Assets 65 Suit Against 65 Successfully Defends 64 LLP Investigates 64 Introduces Revolutionary 64 Copyright Infringement Case 64 Lawsuit Filed 64 Countersues 64 Inequitable Conduct 64 Reach Settlement 64 Shareholder Claims 64 Trademark Suit 64 Issued Patent 64 Settles Fraud 64 Files Lawsuit 64 Denies Motion 64 Non Infringement 64 Lawsuit Brought 64 Antitrust Lawsuit Against 64 Signs Licensing Agreement 64 #cv# [001] 64 Antitrust Complaint 64 Introduces Next Generation 64 Lawsuits Filed 64 Announces Licensing Agreement 64 Court Dismisses 64 Settles Suit 64 Settles Patent Suit 64 Settlement Reached 64 Commercializes 64 Files Patent Application 64 Files Lawsuit Against 64 Seeks Injunction 64 Files Complaint 64 Receives Subpoena 64 Files Antitrust Lawsuit 64 Reaches Settlement 64 Unveils Newest 64 Resolves Dispute 64 Goldfarb Branham Law Firm 63 Suit Filed 63 Settle Antitrust 63 Acacia Subsidiary Enters 63 Gets Favorable Ruling 63 Action Lawsuits 63 Pending Acquisition 63 Refocuses 63 Arthritis Drug 63 Settles Dispute 63 Lawsuit Alleging 63 Confirms Validity 63 Permanent Injunction Against 63 Announces License Agreement 63 Posts Wider Loss 63 #cv# [003] 63 Secures Patent 63 DVD Copying 63 Receives FDA Clearance 63 Lawsuit Against 63 Spins Off 63 Kickback Case 63 Lawsuit Dismissed 63 Licenses Patents 63 Acacia Subsidiary Acquires 63 Sign Licensing Agreement 63 Generic Version 63 Lawsuit Settled 63 Settle Lawsuits 63 Announce Availability 63 Purchases Moore Microprocessor 63 Obtains Exclusive License 63 Shares Plummet 63 Q4 Profit Plunges 63 ENFORCEMENT PROCEEDINGS SEC 63 Antitrust Suit Against 63 Boosts Guidance 63 Plans Job Cuts 62 Trademark Infringement Lawsuit 62 Settles Lawsuits 62 Settles Lawsuit 62 Stock Soars 62 Has Filed 62 Inks Licensing Deal 62 Files IND 62 Obtains Patent 62 Faces Lawsuit 62 Files Provisional 62 Lawsuit Involving 62 Unveils Latest 62 Reach Settlement Agreement 62 Twersky LLP Announces 62 Cross Licensing Agreement 62 Lowers Guidance 62 Mylan Receives Approval 62 Dismiss Lawsuit 62 Q3 Loss Widens 62 Delivers Next Generation 62 Can Proceed 62 Settle Shareholder 62 Malpractice Suit 62 Attorneys Fees 62 Court Invalidates 62 Develop Novel 62 Q2 Loss Narrows 62 Begins Shipping 62 Suits Against 62 Awarded Patents 62 Settle Dispute 62 Patents Covering 62 Settle Lawsuit 62 Posts 4Q Profit 62 Commenced Against 62 Whistleblower Lawsuit 62 FDA Clears 62 Gets Subpoena 62 Q2 Loss Widens 62 Eliminates Need 62 Narrows 4Q Loss 62 Suit Claims 62 Loses Lawsuit 62 Claim Against 62 Teva Provides Update 62 LLP Investigating 62 Posts Loss 62 No. #-# Fed. 62 Achieves Milestone 62 Whistleblower Suit 62 Reduces Debt 62 Million Verdict 62 Shareholder Lawsuits 62 Filed Against 61 Toshiba Develops 61 Announces Definitive Agreement 61 Board Authorizes 61 4Q Profit Soars 61 NTP Sues 61 Files Voluntary 61 False Marking 61 Wrongful Death Lawsuit Filed 61 Files Claim 61 Settles FTC 61 Suit Settled 61 Unveils Innovative 61 Extends Tender Offer 61 Suit Alleges 61 Q4 Loss Narrows 61 Shareholder Investigation 61 Plans Buyback 61 Investigates Claims 61 Faces Suit 61 non infringement invalidity 61 Announces Filing 61 Lawsuit Filed Against 61 Shareholder Suit 61 Q4 Loss Widens 61 Showcases Innovative 61 Settle Dispute Over 61 Jury Sides 61 Seek Dismissal 61 Settle Suits 61 Suits Filed 61 Cholesterol Drug 61 Slashes Prices 61 Posts 4Q Loss 61 Q3 Loss Narrows 61 Amend Merger Agreement 61 Patent Covering 61 Suit Vs 61 3Q Loss Widens 61 Taro Receives 61 Announce Early Termination 61 Antitrust Ruling 61 Regains Compliance 61 Expand Relationship 61 Investigating Shareholder 61 Terminate Merger Agreement 61 4Q Loss Widens 61 Posts 1Q Profit 61 Restate Results 61 License Pact 61 Unveils Groundbreaking 61 Widely Used 61 Narrows 1Q 61 Streamlines Operations 61 Q4 Profit Drops 61 Announces Tentative Approval 61 Settle Fraud 61 CFO Resigns 61 Counterclaims 61 Provides Update Regarding 61 Seeks Dismissal Of 61 Successfully Completes Tender Offer 61 Quadruples 61 Settles Claim 61 Introduces Enhanced 61 Visual Voicemail Patent Infringement 61 Blood Thinner 61 Claim Filed 61 4Q Profit Down 61 Drops Suit 61 4Q Profit Slips 61 Lawsuits Filed Against 61 Unsolicited Proposal From 61 Introduces Innovative 61 Explore Strategic Alternatives 61 File Sharing Case 61 Recall Issued 61 Wider Loss 61 Shares Soar 61 Found Liable 61 Above Estimates 61 Piracy Lawsuits 61 Significantly Increases 61 Permanent Injunction 61 Tablet Device 61 Stock Plunges 61 Announce Collaboration 60 Court Reverses 60 alleging patent infringement 60 Announce Licensing Agreement 60 Narrows Loss 60 Resolves Litigation 60 Faces Delisting 60 Licensing Deal 60 Jury Decides 60 Misled Investors 60 1Q Loss Widens 60 Files Amended 60 4Q Profit Falls 60 KB Home Swings 60 Judge Tosses 60 Nasdaq Delisting Notice 60 Announces Proposed Settlement 60 Files Petition 60 Lawsuit Dismissed Against 60 Files Amended Complaint 60 4Q Profit Surges 60 Submits Supplemental 60 Analyst Upgrade 60 Not Liable 60 Chip Makers 60 Stock Tumbles 60 2Q Loss Widens 60 Suit Dismissed 60 Generic Versions 60 Execs Plead Guilty 60 Rehear 60 Q3 Profit Jumps 60 Unveils Revolutionary 60 Milberg Weiss Announces 60 Announce Expiration 60 Nearly Triples 60 1Q Profit Falls 60 Unfair Competition 60 Delays Filing 60 Terminates Merger Agreement 60 Enters Into Settlement Agreement 60 Assigned Patent 60 Wider Than Expected 60 Provides Preliminary 60 Analyst Predicts 60 Accounting Errors 60 Debuts Next Generation 60 Restate Financials 60 Extends Leadership 60 Nasdaq Listing Requirements 60 Granted Early Termination 60 Jointly Develop 60 FDA Warns 60 File Sharers 60 Beats Expectations 60 Action Suit Filed 60 Injunctive Relief 60 Regains Compliance With 60 FCC Approves 60 Expands Portfolio 60 Slashes Guidance 60 Q2 Profit Plunges 60 Q1 Loss Narrows 60 Reports Receipt 60 Contract Dispute 60 Patent Infringement Complaint 60 Hostile Bid 60 1Q Loss Narrows 60 Completes Enrollment 60 Receives Milestone Payment 60 Wins Injunction 60 Strengthens Position 60 Patent Invalid 60 Suit Filed Against 60 Defamation Case 60 Shares Climb 60 Patented Technology 60 Rehearing En Banc 60 Completes Divestiture 60 Lawsuit Alleges 60 Lodged Against 60 Appeals Court Upholds 60 Shares Surge 60 Posts 2Q Loss 60 Proposed Buyout 60 Jointly Developed 60 Announce Agreement 60 Ruling Upheld 60 Doubles Capacity 60 Settles Suits 60 Slashes Price 60 Settles Lawsuit Against 60 Cuts Costs 60 Judge Dismisses 60 Posts 2Q Profit 60 Wins Approval 60 Unveils Expanded 60 Receives Tentative Approval 60 Completes Patient Enrollment 60 Q2 Profit Plummets 60 Posts Smaller 60 Jury Verdict Against 60 Shares Tumble 60 Age Bias 60 Reconfirms 60 Collaborates With 60 Lawsuit Claims 60 Infringement 60 Infringing 60 purchased Moore Microprocessor 60 Case Involving 60 Rehearing 60 Gets FDA Clearance 60 Profit Dips 60 Civil Suit 60 Complies With 59 Confirms Receipt 59 Posts Wider 4Q Loss 59 Exclusive Licensee 59 Q2 Adj 59 2Q Profit 59 Finalizes Acquisition 59 Execs Charged 59 Dismiss Case 59 2Q Profit Down 59 Judge Nixes 59 Regains Full 59 Updates Guidance 59 Fraud Suit 59 Wrongful Termination 59 Trims Loss 59 Raises Guidance 59 Applauds FCC 59 1Q Profit Down 59 Posts Strong 59 Court Upholds Dismissal 59 CybeRelease Decliners 59 Solution Accelerates 59 Jury Finds 59 Graphics Chips 59 Settle Suit 59 Posts Lower 59 Boosts Outlook 59 Expands Capabilities 59 Meets Estimates 59 Receives Notice 59 Achieves Significant 59 Camera Phones 59 Announces Early Termination 59 Ships #th 59 Class Action Lawsuit 59 Summary Judgment Motion 59 Platform Enables 59 Upholds 59 Other OTC MNDP 59 Q2 Profit Surges 59 Receives Certification 59 Summary Judgment Motions 59 Inks Pact 59 Planned Acquisition 59 Justices Weigh 59 Fistel LLC Announces 59 Narrower Loss 59 3Q Profit Up 59 Nears Settlement 59 Extends Reach 59 Exec Says 59 3Q Profit Plunges 59 Defamation Lawsuit 59 Witness Tampering 59 Panasonic ReadSoft 59 Reaches Tentative Settlement 59 Receives Positive 59 Woman Suing 59 Successfully Completed 59 Resolve Dispute 59 Q1 Profit Drops 59 1Q Profit 59 Suit Alleging 59 Options Backdating 59 Expand Collaboration 59 Q4 Profit Surges 59 Protects Customers 59 Settle False Claims 59 Extend Partnership 59 Q2 Profit Declines 59 Boosts Dividend 59 FDA Accepts 59 Board Unanimously Rejects 59 Shareholder Lawsuit Against 59 Commercially Available 59 Sign Definitive Agreement 59 Ups Guidance 59 Renews Agreement 59 Expands Scope 59 Investigates Possible 59 Slashes Outlook 59 Restates Earnings 59 Announces Receipt 59 3Q Profit Falls 59 1Q Loss 59 Jointly Announce 59 Misses Views 59 Judge Throws Out 59 Action Filed Against 59 Case Settled 59 Acquires Exclusive 59 Q3 Profit Plunges 59 Provides Guidance 59 Losses Widen 59 Favorable Decision 59 Receives Notice From 59 Losses Narrow 59 Harassment Case 59 3Q Profit Dips 59 Q3 Profit Drops 59 TM MMP Portfolio 59 Exec Sees 59 Epilepsy Drug 59 Accelerate Commercialization 59 Q4 Profit Declines 59 Court Nixes 59 Analyst Downgrade 59 File Lawsuit Against 59 Dramatically Increases 59 Broadens Portfolio 59 Issues Resolved 59 Files Definitive Proxy 59 Employee Sentenced 59 Announces Intent 59 Delay Filing 59 Seeks Damages 59 Derivative Action 59 Court Dismisses Lawsuit 59 1Q Profit Tumbles 59 Ruling Favors 59 Settle Trademark 59 Announce Interoperability 59 Supreme Court Hears 59 Patent Troll 59 Files Complaint Against 59 3Q Profit Drops 59 Jumps Higher 59 Licenses Novel 59 Carbon Monoxide Deaths 59 Libel Suit 59 Guides Inline 59 Amends Agreement 59 4Q Profit Jumps 58 Issues Statement Regarding 58 Casio Fujitsu 58 Receives CE Marking 58 Enters Into Exclusive 58 Demonstrates Commitment 58 Submits NDA 58 Receives Orphan Drug Designation 58 Multimillion Dollar 58 Stockholders Approve Merger 58 4Q Profit Drops 58 Dramatically Expands 58 Posts Quarterly 58 Unsolicited Tender Offer 58 Confirms Commitment 58 Beats Views 58 4Q Loss 58 Secures Additional 58 Stock Option Backdating 58 Exploring Strategic Alternatives 58 Case Dismissed 58 Enters Into License Agreement 58 Ups Bid 58 Ramps Up Production 58 Case Thrown Out 58 Competition G.1 58 Dropped Against 58 Generic Version Of 58 Announces Stockholder Approval 58 Extends Expiration Date 58 Receives Commitment 58 Fortifies 58 Receives Clearance 58 Squares Off 58 Discrimination Case 58 Emotional Distress 58 3Q Profit 58 Immunomedics Announces 58 Murder Plot 58 Provides Status 58 Settles Sexual Harassment 58 Osteoporosis Drug 58 Lawsuit Settlement 58 Cross License Agreement 58 FDA Okays 58 Announces Initiation 58 Complete Merger 58 Court Dismisses Suit 58 PRODUCT SOURCE 58 Delivers Enhanced 58 Update# 58 patent infringement 58 Lowers Price 58 Files Registration Statement 58 Restates Results 58 ARM Processors 58 Revenues Decline 58 Beat Estimates 58 Hits Milestone 58 Misdemeanor Charge 58 Earnings Cheat Sheet 58 Drops Lawsuit 58 Buyout Rumors 58 Extends Offer 58 Court Reverses Ruling 58 Ruling Delayed 58 Settle Lawsuit Over 58 Receives Unsolicited 58 Device Makers 58 Officially Launches 58 Potential Dangers 58 Posts Profit 58 patent infringment 58 Earns Milestone Payment 58 Court Hears Arguments 58 Tactile Feedback 58 3Q Loss 58 2Q Profit Surges 58 Exclusive License 58 Announce Collaboration Agreement 58 Receives Confirmation 58 Strengthens Its 58 Deliver Powerful 58 Piracy Suit 58 Updates Outlooks 58 Regains Nasdaq 58 Partial Settlement 58 Punitive Damages 58 Posts Narrower Loss 58 Civil Penalty 58 Files Patents 58 Reaffirms Outlook 58 Receives NASDAQ 58 Testosterone Gel 58 Being Investigated 58 Sex Harassment 58 Successfully Tested 58 Restructures Debt 58 Discrimination Lawsuit 58 Resolve False Claims 58 Proxy Fight 58 Summary Judgment Order 58 Trial Nears 58 Enters Agreement 58 OxyContin Maker 58 Below Consensus 58 2Q Profit Falls 58 Acquires Assets 58 Q1 Profit Slips 58 Lawsuit Challenging 58 Narrows Guidance 58 Helps Protect 58 Unwraps 58 Cholesterol Lowering Drug 58 Below Estimates 58 resolves patent infringement 58 Reminds Shareholders 58 Obtains Exclusive Rights 58 FDA Panel Recommends 58 Priest Abuse 58 Intellectual Property Portfolio 58 Drug Coated Stent 58 Revises Third Quarter 58 Announces Termination 58 4Q Profit Rises 58 Loss Widens 58 Announces Investigation 58 2Q Profit Up 58 Judge Upholds 58 Misses Expectations 58 Suit Accuses 58 Completes Reverse Merger 58 Distribution Pact 58 Completes Integration 58 Court Overturns 58 Misses Estimates 58 Waiting Period 58 Announce Receipt 58 File Complaint 58 Patent Portfolio 58 Being Sued 58 Has Spiked 58 Biotech Firm 58 NASDAQ Listing Requirements 58 Announce Successful Completion 58 Announces Enhancements 58 Universal Shelf Registration 58 Terminates Contract 58 Guilty Pleas 58 Inappropriate Conduct 58 Posts 3Q 58 Boise Idaho Hynix Semiconductor 58 Posts Wider 58 Completes Purchase Of 58 Generic Protonix 58 Submits Application 58 Net Loss Narrows 58 Panasonic Pentax 58 Previews Earnings 58 Latest Addition 58 Sexual Harassment Claim 58 Flagship Product 58 Q3 Profit Soars 58 Decision Upholding 58 Differentiates 58 Lawsuit Accuses 58 Takeover Speculation 58 Profit Beats Estimates 58 Sexual Harassment Case 57 Posts 3Q Profit 57 Q2 Profit Drops 57 Announce Initiation 57 Fully Functional 57 Reduces Workforce 57 Upholds Ruling 57 Announces Expanded 57 Investigation Relating 57 File Wrongful Death 57 Patent Licensing 57 File Swapping 57 Buyout Bid 57 Espionage Case 57 Litigations 57 Raises Outlook 57 Seeks Buyer 57 Authorizes Additional 57 Manslaughter Charges 57 Certifies 57 Copyright Infringement Lawsuit 57 Taglich Brothers Initiates Coverage 57 Judge Overturns 57 Lawsuit Vs 57 Appeal Denied 57 Regains NASDAQ 57 Completes Merger 57 Sony Laptop Batteries 57 Court Throws Out 57 2Q Loss Narrows 57 Q1 Profit Declines 57 Restate Financial 57 Milestone Payment 57 Manslaughter Charge 57 Shares Plunge 57 Enable Secure 57 Announces Successful Completion 57 Buyout Offer 57 Update8 57 Lowers Outlook 57 Lawyer Argues 57 Firm Sues 57 Court Tosses 57 Files Wrongful Death 57 Lawyers Argue 57 Signs Merger Agreement 57 Q1 Profit Surges 57 Expands Availability 57 3Q Profit Down 57 Employee Sues 57 Conspiracy Charges 57 Develop Innovative 57 Successfully Integrates 57 Wins Injunction Against 57 Q1 Profit Soars 57 Lawsuit Filed Over 57 Fee Dispute 57 Low Dose 57 Unveils Powerful 57 Wrongful Death Case 57 ACACIA ACAC TECH 57 Announce Definitive Agreement 57 Aquires 57 Phicom 57 Terminate Agreement 57 Markman Hearing 57 Woman Found Guilty 57 Extend Collaboration 57 Issues Recall 57 Gets Sued 57 Releases Upgraded 57 Execs Face 57 Appeal Ruling 57 Tops Estimates 57 Judge Declares Mistrial 57 Lawsuits Against 57 Conceals 57 Drug Candidate 57 Defends Itself 57 Commences Tender Offer 57 1Q Profit Slips 57 Leaps Ahead 57 Hagens Berman Investigates 57 NASDAQ Delisting 57 Announces Issuance 57 Possible Breach 57 Subsidiary Receives 57 Beats Estimates 57 More Than Doubles 57 Posts 3Q Loss 57 Witness Testifies 57 Closing Arguments Set 57 Q2 Profit Soars 57 Profit Exceeds Estimates 57 Q3 Profit Surges 57 FDA Approvals 57 Discrimination Suit 57 Extends Collaboration 57 Closing Arguments Begin 57 Q3 Adj 57 2Q Profit Slides 57 Action Lawsuit 57 Obtains Approval 57 Expanded Indication 57 Terminates Agreement 57 Regulatory Clearance 57 Not Infringe 57 Credit Card Fraud 57 Expands Globally 57 Intentional Infliction 57 Finalize Agreement 57 Profit Doubles 57 Diet Pill 57 Judge Clears Way 57 Sell Itself 57 Privacy Concerns 57 Lowers Costs 57 Woman Sues 57 Announces Availability 57 Enters Into Licensing Agreement 57 Lung Cancer Drug 57 ENFORCEMENT PROCEEDINGS 57 Vioxx Suits 57 Rejects Request 57 Questions Loom 57 Faruqi LLP Announces 57 Jury Tampering 57 Trial Ordered 57 Charges Brought 57 Suit Seeks 57 Spears Conservatorship 57 Initiates Enrollment 57 Wrongful Death Suit 57 Q1 Adj 57 Piracy Crackdown 57 Unlocks 57 Supplemental Biologics License Application 57 Completes Sale Of 57 Patents Issued 57 Withdraws Application 57 Hear Arguments 57 Attains 57 Sex Assault Charges 57 Lawyer Quits 57 Moves Towards 57 Spins Out 57 Enters Strategic 57 Gets Approval 57 Outsells 57 2Q Profit Jumps 57 Achieves Record 57 Extend Relationship 57 CEO Exercises Options 57 Present Preclinical Data 57 Buyout Talks 57 Strengthens Commitment 57 Seeks Dismissal 57 Directors Authorizes 57 Q2 Profit Rises 57 Video Codec 57 Loss Narrows 57 Expands Functionality 57 Execs Indicted 57 Approves Merger 57 Subsidiary Enters 57 Forecast Quick Facts 57 Chips Snap 57 Jury Selection Starts 57 File Swappers 57 Receives SFDA Approval 57 Request Denied 57 Q3 Profit Declines 57 Snaps Up 57 Loses Bid 57 Above Consensus 57 Strikes Deal 57 Kodroff PC Announces 57 Judge Hears Arguments 57 Abandons Plans 57 Profit Soars 57 Previously Disclosed 57 Inhaled Insulin 57 Updates Status 57 Expand Scope 57 Reverses Loss 57 Presents Preclinical Data 57 Wizzard Software Announces 57 ONN.tv Report 57 Confirms Filing 57 Provides Shareholder 57 4Q Profit 57 Tortious Interference 57 Posts Higher 57 Feds Seek 57 Has Been Filed 57 Tossed Out 57 Protects Against 57 Settlement Agreement Regarding 57 Alleged Fraud 57 Jury Selection Begins 57 Improves Efficiency 57 Awarded Damages 57 Successfully Completes Acquisition 57 Destroyed Evidence 57 Profit Drops 57 Gets Nasty 57 Felony Charges 57 Lowers Forecast 57 Clears Path 57 Lifts FY# Outlook 57 Court Upholds 57 Formalizes 57 Introduces Powerful 57 Vacates 57 Enables Faster 57 Settle Claims 57 More Than Doubled 57 Acquire Controlling Interest 56 Announce Merger Agreement 56 Announces Commencement 56 Loss Shrinks 56 Offers Glimpse 56 Q1 Profit Jumps 56 Higher Expenses 56 3Q Profit Rises 56 3Q Profit Jumps 56 OTCBB OPTI 56 Announces Effective Date 56 Milberg LLP Announces 56 Broadens 56 Reaches Agreement 56 4Q Profit Up 56 Blood Clotting 56 Enter Into 56 Launches Redesigned Website 56 Secures Funding 56 Penetrates 56 Weight Loss Drug 56 Slowing Growth 56 Restate Earnings 56 Boosts Buyback 56 Announces Shareholder Approval 56 Successfully Launches 56 Court Reinstates 56 Earnings Decline 56 Pregnancy Discrimination 56 Judge Refuses 56 Posts 1Q 56 Rumors Abound 56 Share Repurchases

Back to home page